Systematic review and meta-analysis of a urine-based pneumococcal antigen test for diagnosis of community-acquired pneumonia caused by Streptococcus pneumoniae

Journal of Clinical Microbiology

Volumn 51, Issue 7, 2013, Pages 2303-2310

  Sinclair, Alison ^a   Xie, Xuanqian ^a   Teltscher, Marty ^a   Dendukuri, Nandini ^a,b  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN;

ANTIGEN DETECTION; ARTICLE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BLOOD CULTURE; COMMUNITY ACQUIRED PNEUMONIA; DIAGNOSTIC ACCURACY; DIAGNOSTIC KIT; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; HUMAN; INTERMETHOD COMPARISON; META ANALYSIS; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; SYSTEMATIC REVIEW; URINALYSIS; ADULT; AGED; COMMUNITY-ACQUIRED INFECTIONS; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; EVALUATION STUDY; FEMALE; IMMUNOAFFINITY CHROMATOGRAPHY; IMMUNOLOGY; MALE; MIDDLE AGED; PNEUMONIA, PNEUMOCOCCAL; PROCEDURES; URINE;

STREPTOCOCCUS PNEUMONIAE;

ADULT; AGED; ANTIGENS, BACTERIAL; CLINICAL LABORATORY TECHNIQUES; COMMUNITY-ACQUIRED INFECTIONS; DIAGNOSTIC TESTS, ROUTINE; FEMALE; HUMANS; IMMUNOCHROMATOGRAPHY; MALE; MIDDLE AGED; PNEUMONIA, PNEUMOCOCCAL; SENSITIVITY AND SPECIFICITY; STREPTOCOCCUS PNEUMONIAE;

EID: 84879442131     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00137-13     Document Type: Article

References (54)

1. van der Poll T, Opal SM. 2009. Pathogenesis, treatment, and prevention of pneumococcal pneumonia. Lancet 374:1543-1556.
2. Selickman J, Paxos M, File TM, Seltzer R, Bonilla H. 2010. Performance measure of urinary antigen in patients with Streptococcus pneumoniae bacteremia. Diagn. Microbiol. Infect. Dis. 67:129-133.
3. Genne D, Siegrist HH, Lienhard R. 2006. Enhancing the etiologic diagnosis of community-acquired pneumonia in adults using the urinary antigen assay (Binax NOW). J. Infect. Dis. 10:124-128.
4. Ishida T, Hashimoto T, Arita M, Tojo Y, Tachibana H, Jinnai M. 2004. A 3-year prospective study of a urinary antigen-detection test for Streptococcus pneumoniae in community-acquired pneumonia: utility and clinical impact on the reported etiology. J. Infect. Chemother. 10:359-363.
5. Matta M, Kerneis S, Day N, Lescat M, Buu HA, Varon E, Gutmann L, Mainardi JL. 2010. Do clinicians consider the results of the BinaxNOW Streptococcus pneumoniae urinary antigen test when adapting antibiotic regimens for pneumonia patients? Clin. Microbiol. Infect. 16:1389-1393.
6. Marcos MA, Jimenez de Anta MT, de la Bellacasa JP, Gonzalez J, Martinez E, Garcia E, Mensa J, de Roux A, Torres A. 2003. Rapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults. Eur. Respir. J. 21:209-214.
7. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, Dowell SF, File TM, Jr, Musher DM, Niederman MS, Torres A, Whitney CG. 2007. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of communityacquired pneumonia in adults. Clin. Infect. Dis. 44(Suppl 2):S27-S72.
8. Roson B, Carratala J, Verdaguer R, Dorca J, Manresa F, Gudiol F. 2000. Prospective study of the usefulness of sputum Gram stain in the initial approach to community-acquired pneumonia requiring hospitalization. Clin. Infect. Dis. 31:869-874.
9. Mandell L. 2010. Prospective randomised study to compare empirical treatment versus targeted treatment on the basis of the urine antigen results in hospitalised patients with community-acquired pneumonia. Thorax 65:93-94.
10. Yu VL, Stout JE. 2009. Rapid diagnostic testing for community-acquired pneumonia: can innovative technology for clinical microbiology be exploited? Chest 136:1618-1621.
11. Yu VL. 2011. A clinical solution to antimicrobial resistance in community-acquired pneumonia: narrowing the spectrum of antimicrobial therapy. Arch. Intern. Med. 171:172-173.
12. Hadgu A, Dendukuri N, Hilden J. 2005. Evaluation of nucleic acid amplification tests in the absence of a perfect gold-standard test: a review of the statistical and epidemiologic issues. Epidemiology 16:604-612.
13. Dendukuri N, Schiller I, Joseph L, Pai M. 2012. Bayesian meta-analysis of the accuracy of a test for tuberculous pleuritis in the absence of a gold standard reference. Biometrics 68:1285-1293.
14. Klugman KP, Madhi SA, Albrich WC. 2008. Novel approaches to the identification of Streptococcus pneumoniae as the cause of communityacquired pneumonia. Clin. Infect. Dis. 47(Suppl 3):S202-S206.
15. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. 2003. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMCMed. Res. Methodol. 3:25. doi:10.1186/1471-2288-3-25.
16. Rutter CM, Gatsonis CA. 2001. A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations. Stat. Med. 20:2865-2884.
17. Macaskill P, Gatsonis C, Deeks JJ, Harbord RM, Takwoingi Y. 2010. Analysing and presenting results. In Deeks JJ, Bossuyt PM, Gatsonis C (ed), Cochrane handbook for systematic reviews of diagnostic test accuracy, version 1.0. The Cochrane Collaboration. http://srdta.cochrane.org/sites/srdta.cochrane. org/files/uploads/Chapter 10-Version 1.0.pdf.
18. Torrance-Rynard VL, Walter SD. 1997. Effects of dependent errors in the assessment of diagnostic test performance. Stat. Med. 16:2157-2175.
19. Spiegelhalter DJ, Best NG, Carlin BR, van der Linde A. 2002. Bayesian measures of model complexity and fit (with discussion). J. R. Stat. Soc. B Stat. Methodol. 64:583-639.
20. Lunn DJ, Thomas A, Best N, Spiegelhalter D. 2000. WinBUGS. A Bayesian modelling framework: concepts, structure, and extensibility. Stat. Comput. 10:325-337.
21. Development Core Team R. 2011. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria.
22. Johansson N, Kalin M, Annika Giske T-LCG, Hedlund J. 2010. Etiology of community-acquired pneumonia: increased microbiological yield with new diagnostic methods. Clin. Infect. Dis. 50:202-209.
23. Shibli F, Chazan B, Nitzan O, Flatau E, Edelstein H, Blondheim O, Raz R, Colodner R. 2010. Etiology of community-acquired pneumonia in hospitalized patients in northern Israel. Isr. Med. Assoc. J. 12:477-482.
24. Sorde R, Falco V, Lowak M, Domingo E, Ferrer A, Burgos J, Puig M, Cabral E, Len O, Pahissa A. 2011. Current and potential usefulness of pneumococcal urinary antigen detection in hospitalized patients with community-acquired pneumonia to guide antimicrobial therapy. Arch. Intern. Med. 171:166-172.
25. Perelló R, Miró O, Marcos MA, Almela M, Bragulat E, Sánchez M, Agustí C, Miro JM, Moreno A. 2010. Predicting bacteremic pneumonia in HIV-1-infected patients consulting the ED. Am. J. Emerg. Med. 28: 454-459.
26. Segonds C, Le GA, Chabanon G. 2010. Assessment of the contribution of the immunochromatographic pneumococcal urinary antigen test to the etiological diagnosis of pneumonia in hospitalized adults. Pathol. Biol. (Paris) 58:117-122. (In French.)
27. Smith MD, Sheppard CL, Hogan A, Harrison TG, Dance DA, Derrington P, George RC. 2009. Diagnosis of Streptococcus pneumoniae infections in adults with bacteremia and community-acquired pneumonia: clinical comparison of pneumococcal PCR and urinary antigen detection. J. Clin. Microbiol. 47:1046-1049.
28. Charles PG, Whitby M, Fuller AJ, Stirling R, Wright AA, Korman TM, Holmes PW, Christiansen KJ, Waterer GW, Pierce RJ, Mayall BC, Armstrong JG, Catton MG, Nimmo GR, Johnson B, Hooy M, Grayson ML. 2008. The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy. Clin. Infect. Dis. 46:1513-1521.
29. Hohenthal U, Vainionpää R, Meurman O, Vahtera A, Katiskalahti T, Nikoskelainen J, Kotilainen P. 2008. Aetiological diagnosis of community acquired pneumonia: utility of rapid microbiological methods with respect to disease severity. Scand. J. Infect. Dis. 40:131-138.
30. Weatherall C, Paoloni R, Gottlieb T. 2008. Point-of-care urinary pneumococcal antigen test in the emergency department for community acquired pneumonia. Emerg. Med. J. 25:144-148.
31. Díaz A, Barria P, Niederman M, Restrepo MI, Dreyse J, Fuentes G, Couble B, Saldias F. 2007. Etiology of community-acquired pneumonia in hospitalized patients in Chile: the increasing prevalence of respiratory viruses among classic pathogens. Chest 131:779-787.
32. del Mar García-Suárez M, Cima-Cabal MD, Villaverde R, Espinosa E, Falguera M, de Los Toyos JR, Vázquez F, Méndez FJ. 2007. Performance of a pneumolysin enzyme-linked immunosorbent assay for diagnosis of pneumococcal infections. J. Clin. Microbiol. 45:3549-3554.
33. Kobashi Y, Yoshida K, Miyashita N, Niki Y, Matsushima T. 2007. Evaluating the use of a Streptococcus pneumoniae urinary antigen detection kit for the management of community-acquired pneumonia in Japan. Respiration 74:387-393.
34. Andreo F, Domínguez J, Ruiz J, Blanco S, Arellano E, Prat C, Morera J, Ausina V. 2006. Impact of rapid urine antigen tests to determine the etiology of community-acquired pneumonia in adults. Respir. Med. 100: 884-891.
35. Ercis S, Ergin A, Sahin GO, Hascelik G, Uzun O. 2006. Validation of urinary antigen test for Streptococcus pneumoniae in patients with pneumococcal pneumonia. Jpn. J. Infect. Dis. 59:388-390.
36. Lasocki S, Scanvic A, Le Turdu F, Restoux A, Mentec H, Bleichner G, Sollet JP. 2006. Evaluation of the BinaxNOW Streptococcus pneumoniae urinary antigen assay in intensive care patients hospitalized for pneumonia. Intensive Care Med. 32:1766-1772.
37. Tzeng DH, Lee YL, Lin YH, Tsai CA, Shi ZY. 2006. Diagnostic value of the Binax NOW assay for identifying a pneumococcal etiology in patients with respiratory tract infection. J. Microbiol. Immunol. Infect. 39:39-44.
38. Lauderdale TL, Chang FY, Ben RJ, Yin HC, Ni YH, Tsai JW, Cheng SH, Wang JT, Liu YC, Cheng YW, Chen ST, Fung CP, Chuang YC, Cheng HP, Lu DC, Liu CJ, Huang IW, Hung CL, Hsiao CF, Ho M. 2005. Etiology of community acquired pneumonia among adult patients requiring hospitalization in Taiwan. Respir. Med. 99:1079-1086.
39. Van Der Eerden MM, Vlaspolder F, De Graaff CS, Groot T, Jansen HM, Boersma WG. 2005. Value of intensive diagnostic microbiological investigation in low-and high-risk patients with community-acquired pneumonia. Eur. J. Clin. Microbiol. Infect. Dis. 24:241-249.
40. Rosón B, Fernández-Sabé N, Carratalà J, Verdaguer R, Dorca J, Manresa F, Gudiol F. 2004. Contribution of a urinary antigen assay (Binax NOW) to the early diagnosis of pneumococcal pneumonia. Clin. Infect. Dis. 38:222-226.
41. Stralin K, Kaltoft MS, Konradsen HB, Olcen P, Holmberg H. 2004. Comparison of two urinary antigen tests for establishment of pneumococcal etiology of adult community-acquired pneumonia. J. Clin. Microbiol. 42:3620-3625.
42. Butler JC, Bosshardt SC, Phelan M, Moroney SM, Tondella ML, Farley MM, Schuchat A, Fields BS. 2003. Classical and latent class analysis evaluation of sputum polymerase chain reaction and urine antigen testing for diagnosis of pneumococcal pneumonia in adults. J. Infect. Dis. 187: 1416-1423.
43. Farina C, Arosio M, Vailati F, Moioli F, Goglio A. 2002. Urinary detection of Streptococcus pneumoniae antigen for diagnosis of pneumonia. New Microbiol. 25:259-263.
44. Burel E, Dufour P, Gauduchon V, Jarraud S, Etienne J. 2001. Evaluation of a rapid immunochromatographic assay for detection of Streptococcus pneumoniae antigen in urine samples. Eur. J. Clin. Microbiol. Infect. Dis. 20:840-841.
45. Murdoch DR, Laing RT, Mills GD, Karalus NC, Town GI, Mirrett S, Reller LB. 2001. Evaluation of a rapid immunochromatographic test for detection of Streptococcus pneumoniae antigen in urine samples from adults with community-acquired pneumonia. J. Clin. Microbiol. 39: 3495-3498.
46. Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, Leeflang MM, Sterne JA, Bossuyt PM. 2011. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann. Intern. Med. 155:529-536.
47. Boulware DR, Daley CL, Merrifield C, Hopewell PC, Janoff EN. 2007. Rapid diagnosis of pneumococcal pneumonia among HIV-infected adults with urine antigen detection. J. Infect. 55:300-309.
48. Gatsonis C, Paliwal P. 2006. Meta-analysis of diagnostic and screening test accuracy evaluations: methodologic primer. Am. J. Roentgenol. 187: 271-281.
49. Musher DM, Montoya R, Wanahita A. 2004. Diagnostic value of microscopic examination of Gram-stained sputum and sputum cultures in patients with bacteremic pneumococcal pneumonia. Clin. Infect. Dis. 39: 165-169.
50. Porcel JM, Ruiz-González A, Falguera M, Nogués A, Galindo C, Carratalá J, Esquerda A. 2007. Contribution of a pleural antigen assay (Binax NOW) to the diagnosis of pneumococcal pneumonia. Chest 131:1442-1447.
51. Falguera M, Ruiz-González A, Schoenenberger JA, Touzón C, Gázquez I, Galindo C, Porcel JM. 2010. Prospective, randomised study to compare empirical treatment versus targeted treatment on the basis of the urine antigen results in hospitalised patients with community-acquired pneumonia. Thorax 65:101-106.
52. van der Eerden MM, Vlaspolder F, de Graaff CS, Groot T, Bronsveld W, Jansen HM, Boersma WG. 2005. Comparison between pathogen directed antibiotic treatment and empirical broad spectrum antibiotic treatment in patients with community acquired pneumonia: a prospective randomised study. Thorax 60:672-678.
53. Johansson N, Kalin M, Giske CG, Hedlund J. 2008. Quantitative detection of Streptococcus pneumoniae from sputum samples with real-time quantitative polymerase chain reaction for etiologic diagnosis of community-acquired pneumonia. Diagn. Microbiol. Infect. Dis. 60:255-261.
54. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, Coley CM, Marrie TJ, Kapoor WN. 1997. A prediction rule to identify low-risk patients with community-acquired pneumonia. N. Engl. J. Med. 336:243-250.